FTXH vs. QCLN
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and QCLN (First Trust NASDAQ Clean Edge Green Energy Index Fund) are both exchange-traded funds - FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index, while QCLN is a Alternative Energy Equities fund tracking the NASDAQ Clean Edge Green Energy. Both are passively managed. Over the past 5 years, FTXH returned 8.33%/yr vs 2.04%/yr for QCLN. At a 0.39 correlation, their price movements are largely independent. Both charge a 0.60% expense ratio.
Performance
FTXH vs. QCLN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 7.62% return, which is significantly lower than QCLN's 52.00% return.
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
QCLN
- 1D
- -0.62%
- 1M
- 13.54%
- YTD
- 52.00%
- 6M
- 46.53%
- 1Y
- 117.87%
- 3Y*
- 12.00%
- 5Y*
- 2.04%
- 10Y*
- 17.14%
FTXH vs. QCLN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
QCLN First Trust NASDAQ Clean Edge Green Energy Index Fund | 52.00% | 31.81% | -18.86% | -10.02% | -30.37% | -3.21% | 184.00% | 42.65% | -12.38% | 32.34% |
Correlation
The correlation between FTXH and QCLN is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2016 | 0.39 |
FTXH vs. QCLN - Sectors Allocation Comparison
Sectors
FTXH
QCLN
Healthcare
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
FTXH
QCLN
-
Basic Materials
FTXH
-
QCLN
Communication Services
FTXH
-
QCLN
-
Consumer Cyclical
FTXH
-
QCLN
Consumer Defensive
FTXH
-
QCLN
-
Energy
FTXH
-
QCLN
Financial Services
FTXH
-
QCLN
Industrials
FTXH
-
QCLN
Real Estate
FTXH
-
QCLN
-
Technology
FTXH
-
QCLN
Utilities
FTXH
-
QCLN
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. QCLN — Risk / Return Rank
FTXH
QCLN
FTXH vs. QCLN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTXH | QCLN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.41 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.47 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 5.32 | 7.48 | -2.16 |
| Martin ratioReturn relative to average drawdown | 15.35 | 25.77 | -10.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FTXH | QCLN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.32 | 3.42 | -1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.05 | +0.46 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.49 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.20 | +0.19 |
Drawdowns
FTXH vs. QCLN - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum QCLN drawdown of -76.18%. Use the drawdown chart below to compare losses from any high point for FTXH and QCLN.
Loading charts...
Drawdown Indicators
| FTXH | QCLN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -76.18% | +44.07% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -15.86% | +8.39% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -56.08% | +36.57% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -69.49% | +49.98% |
Max Drawdown (10Y)Largest decline over 10 years | — | -71.73% | — |
Current DrawdownCurrent decline from peak | -0.45% | -21.47% | +21.02% |
Average DrawdownAverage peak-to-trough decline | -5.84% | -43.44% | +37.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 4.59% | -2.01% |
Volatility
FTXH vs. QCLN - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.38%, while First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN) has a volatility of 12.57%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than QCLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | QCLN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.38% | 12.57% | -7.19% |
Volatility (6M)Calculated over the trailing 6-month period | 11.96% | 26.03% | -14.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.14% | 34.68% | -17.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.34% | 37.96% | -21.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.43% | 34.90% | -16.47% |
FTXH vs. QCLN - Expense Ratio Comparison
Both FTXH and QCLN have an expense ratio of 0.60%.
Dividends
FTXH vs. QCLN - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.19%, more than QCLN's 0.15% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
QCLN First Trust NASDAQ Clean Edge Green Energy Index Fund | 0.15% | 0.25% | 0.87% | 0.76% | 0.33% | 0.01% | 0.30% | 0.85% | 1.03% | 0.45% | 1.24% | 0.72% |
Frequently Asked Questions
FTXH and QCLN have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QCLN has higher volatility (12.57%) compared to FTXH (5.38%). In terms of maximum drawdown, FTXH dropped -32.11% vs QCLN's -76.18%.
On 5-year performance, FTXH leads with 8.33% vs 2.04% for QCLN. Both ETFs have the same 0.60% expense ratio. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.33% return vs 2.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH and QCLN have the same expense ratio: 0.60% per year.
FTXH has the higher dividend yield at 1.19%, compared with 0.15% for QCLN.
FTXH is categorized as Health & Biotech Equities, while QCLN is Alternative Energy Equities. FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while QCLN tracks NASDAQ Clean Edge Green Energy.
QCLN currently has the higher Sharpe Ratio (3.42 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and QCLN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer